406 related articles for article (PubMed ID: 8539235)
1. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
[TBL] [Abstract][Full Text] [Related]
2. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma.
Day SJ; Nelson M; Rosenthal H; Vergara GG; Bridge JA
Genes Chromosomes Cancer; 1997 Dec; 20(4):425-7. PubMed ID: 9408761
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N
Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568
[TBL] [Abstract][Full Text] [Related]
4. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma.
Stenman G; Andersson H; Mandahl N; Meis-Kindblom JM; Kindblom LG
Int J Cancer; 1995 Aug; 62(4):398-402. PubMed ID: 7635565
[TBL] [Abstract][Full Text] [Related]
5. Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma.
Turc-Carel C; Dal Cin P; Rao U; Karakousis C; Sandberg AA
Cancer Genet Cytogenet; 1988 Jan; 30(1):145-50. PubMed ID: 3422040
[TBL] [Abstract][Full Text] [Related]
6. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?
Rubin BP; Fletcher JA
Adv Anat Pathol; 1999 Jul; 6(4):204-12. PubMed ID: 10410173
[TBL] [Abstract][Full Text] [Related]
7. Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).
Bjerkehagen B; Dietrich C; Reed W; Micci F; Saeter G; Berner A; Nesland JM; Heim S
Virchows Arch; 1999 Nov; 435(5):524-30. PubMed ID: 10592057
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
[TBL] [Abstract][Full Text] [Related]
9. Translocation (9;22)(q22;q12). A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma.
Hirabayashi Y; Ishida T; Yoshida MA; Kojima T; Ebihara Y; Machinami R; Ikeuchi T
Cancer Genet Cytogenet; 1995 May; 81(1):33-7. PubMed ID: 7773957
[TBL] [Abstract][Full Text] [Related]
10. Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia.
Orvieto E; Furlanetto A; Laurino L; Dei Tos AP
Semin Diagn Pathol; 2001 Nov; 18(4):267-73. PubMed ID: 11757867
[TBL] [Abstract][Full Text] [Related]
11. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
12. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2).
Harris M; Coyne J; Tariq M; Eyden BP; Atkinson M; Freemont AJ; Varley J; Attwooll C; Telford N
Am J Surg Pathol; 2000 Jul; 24(7):1020-6. PubMed ID: 10895826
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.
Brody RI; Ueda T; Hamelin A; Jhanwar SC; Bridge JA; Healey JH; Huvos AG; Gerald WL; Ladanyi M
Am J Pathol; 1997 Mar; 150(3):1049-58. PubMed ID: 9060841
[TBL] [Abstract][Full Text] [Related]
14. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry.
Orndal C; Carlén B; Akerman M; Willén H; Mandahl N; Heim S; Rydholm A; Mitelman F
Cytopathology; 1991; 2(5):261-70. PubMed ID: 1782363
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q11) translocation presenting initially as a solid variant devoid of myxoid areas.
Reid R; de Silva MV; Paterson L
Int J Surg Pathol; 2003 Apr; 11(2):137-41. PubMed ID: 12754636
[TBL] [Abstract][Full Text] [Related]
18. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases.
Jakowski JD; Wakely PE
Cancer; 2007 Oct; 111(5):298-305. PubMed ID: 17676582
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
20. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics.
Hisaoka M; Hashimoto H
Pathol Int; 2005 Aug; 55(8):453-63. PubMed ID: 15998372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]